Molinalogo

Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA)

37.36%

40.38%

64.90%

Annual Dental Visits (ADV) Total

47.35%

50.31%

54.60%

Antidepressant Medication Management (AMM) Effective Continuation Phase Treatment

38.22%

36.70%

46.74%

Appropriate Testing for Pharyngitis (CWP)

76.50%

78.88%

77.56%

Appropriate Treatment for Upper Respiratory Infection (URI)

86.31%

93.91%

93.08%

Asthma Medication Ratio (AMR) Total

61.52%

61.31%

69.41%

Avoidance of Antibiotic Treatment for Acute Bronchitis / Bronchiolitis (AAB)

59.52%

71.37%

66.19%

Blood Pressure Control (<140/90) for Patients With Diabetes (BPD)

66.67%

66.42%

68.61%

Breast Cancer Screening (BCS)

50.46%

53.07%

55.25%

Cervical Cancer Screening (CCS)

65.21%

64.48%

59.85%

Childhood Immunization Status (CIS) Combination #10

29.93%

25.69%

35.04%

Chlamydia Screening in Women (CHL) Total

61.38%

62.54%

61.07%

Controlling High Blood Pressure (CBP)

55.47%

60.34%

65.45%

Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD)

74.14%

77.30%

80.86%

Eye Exam for Patients With Diabetes (EED)

37.96%

41.85%

56.20%

Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence (FUA) 7-Day Follow-Up Total

19.65%

28.45%

27.73%

Follow-Up After Emergency Department Visit for Mental Illness (FUM) 7-Day Follow-Up Total

43.30%

40.41%

46.35%

Follow-Up After Hospitalization for Mental Illness (FUH) 7-Day Follow-Up Total

45.68%

46.79%

41.03%

Follow-Up After High-Intensity Care for Substance Use Disorder (FUI) 7-Day Follow-Up Total

27.13%

25.38%

37.31%

Follow-Up for Children Prescribed ADHD Medication (ADD) Continuation and Maintenance Phase

50.00%

53.70%

57.90%

Hemoglobin A1c Control for Patients With Diabetes (HBD) HbA1c Control (<8%)

47.69%

49.64%

55.72%

Immunizations for Adolescents (IMA) Combination #2

39.42%

38.20%

38.93%

Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET) Engagement of AOD Treatment Total

16.45%

14.60%

16.94%

Kidney Health Evaluation for Patients with Diabetes (KED)

41.54%

30.52%

38.80%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) Total

17.57%

30.43%

39.01%

Pharmacotherapy for Opioid Use Disorder (POD) Total

29.28%

24.68%

31.93%

Pharmacotherapy Management of COPD Exacerbation (PCE) Systemic Corticosteroids

82.81%

78.57%

75.79%

Pharmacotherapy Management of COPD Exacerbation (PCE) Bronchodilator

89.06%

85.71%

86.96%

Plan All-Cause Readmissions (PCR) Observed-to-Expected Ratio 18-64 Years

106.49%

83.71%

≤ 92.72%

Prenatal and Postpartum Care (PPC) Timeliness of Prenatal Care

82.97%

86.37%

86.86%

Prenatal and Postpartum Care (PPC) Postpartum Care

68.61%

80.05%

80.78%

Prenatal Immunization Status (PRS) Combination Rate

29.27%

25.90%

25.81

Risk of Continued Opioid Use (COU) 31-Day Total

4.35%

4.60%

≤ 2.45%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Received Statin Therapy Total

81.58%

86.00%

81.64%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Statin Adherence 80% Total

72.04%

73.64%

73.63%

Statin Therapy for Patients with Diabetes (SPD) Received Statin Therapy

64.35%

63.52%

67.07%

Statin Therapy for Patients with Diabetes (SPD) Statin Adherence 80%

66.92%

63.93%

70.37%

Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) Total

47.83%

50.00%

63.89%

Use of Imaging Studies for Low Back Pain (LBP)

77.26%

74.88%

75.44%

Use of Opioids at High Dosage (HDO)

26.91%

30.57%

≤ 2.19%

Use of Opioids from Multiple Providers (UOP) Multiple Prescribers and Multiple Pharmacies

1.52%

1.67%

≤ 0.87%

Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) BMI Percentile

71.53%

71.53%

83.21%